168 related articles for article (PubMed ID: 10552965)
1. Prognostic implications of the differentiation inhibitory factor nm23-H1 protein in the plasma of aggressive non-Hodgkin's lymphoma.
Niitsu N; Okabe-Kado J; Kasukabe T; Yamamoto-Yamaguchi Y; Umeda M; Honma Y
Blood; 1999 Nov; 94(10):3541-50. PubMed ID: 10552965
[TBL] [Abstract][Full Text] [Related]
2. Serum nm23-H1 protein as a prognostic factor for indolent non-Hodgkin's lymphoma.
Niitsu N; Okamoto M; Okabe-Kado J; Takagi T; Yoshida T; Aoki S; Honma Y; Hirano M
Leukemia; 2001 May; 15(5):832-9. PubMed ID: 11368446
[TBL] [Abstract][Full Text] [Related]
3. Serum nm23-H1 protein as a prognostic factor in hematological malignancies.
Okabe-Kado J
Leuk Lymphoma; 2002 Apr; 43(4):859-67. PubMed ID: 12153176
[TBL] [Abstract][Full Text] [Related]
4. Serum nm23-H1 protein as a prognostic factor in aggressive non-Hodgkin lymphoma.
Niitsu N; Okabe-Kado J; Okamoto M; Takagi T; Yoshida T; Aoki S; Hirano M; Honma Y
Blood; 2001 Mar; 97(5):1202-10. PubMed ID: 11222361
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of nm23-H1 proteins expressed on cell surface in non-Hodgkin's lymphoma.
Niitsu N; Honma Y; Iijima K; Takagi T; Higashihara M; Sawada U; Okabe-Kado J
Leukemia; 2003 Jan; 17(1):196-202. PubMed ID: 12529678
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of the differentiation inhibitory factor nm23-H1 protein and their clinical implications in acute myelogenous leukemia.
Niitsu N; Okabe-Kado J; Nakayama M; Wakimoto N; Sakashita A; Maseki N; Motoyoshi K; Umeda M; Honma Y
Blood; 2000 Aug; 96(3):1080-6. PubMed ID: 10910925
[TBL] [Abstract][Full Text] [Related]
7. Expression of nm23-H1 is associated with poor prognosis in peripheral T-cell lymphoma.
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Honma Y; Higashihara M; Okabe-Kado J; Hirano M;
Br J Haematol; 2003 Nov; 123(4):621-30. PubMed ID: 14616965
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of mm23-H1 protein and their clinical implications in malignant lymphoma].
Niitsu N
Rinsho Ketsueki; 2001 Dec; 42(12):1155-61. PubMed ID: 11828717
[No Abstract] [Full Text] [Related]
9. [The prognostic relation of nm23-H1/NDPK-A with leukemia and lymphoma].
Li HY; Liu JS; Wang YF
Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):74-7. PubMed ID: 12778818
[No Abstract] [Full Text] [Related]
10. Evaluation by multivariate analysis of the differentiation inhibitory factor nm23 as a prognostic factor in acute myelogenous leukemia and application to other hematologic malignancies.
Yokoyama A; Okabe-Kado J; Wakimoto N; Kobayashi H; Sakashita A; Maseki N; Nakamaki T; Hino Ki; Tomoyasu S; Tsuruoka N; Motoyoshi K; Nagata N; Honma Y
Blood; 1998 Mar; 91(6):1845-51. PubMed ID: 9490665
[TBL] [Abstract][Full Text] [Related]
11. nm23-H1 protein expression and gene mutation in 150 patients with non-Hodgkin's lymphomas.
Lee JH; Cho SJ; Zhang X; Zheng Z; Lee ES; Kim A; Kim YS; Chae YS; Kim I
J Korean Med Sci; 2006 Aug; 21(4):645-51. PubMed ID: 16891807
[TBL] [Abstract][Full Text] [Related]
12. Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome.
Ito Y; Okabe-Kado J; Honma Y; Iwase O; Shimamoto T; Ohyashiki JH; Ohyashiki K
Leukemia; 2002 Feb; 16(2):165-9. PubMed ID: 11840281
[TBL] [Abstract][Full Text] [Related]
13. Variability of nm23-H1/NDPK-A expression in human lymphomas and its relation to tumour aggressiveness.
Aryee DN; Simonitsch I; Mosberger I; Kos K; Mann G; Schlögl E; Pötschger U; Gadner H; Radaszkiewicz T; Kovar H
Br J Cancer; 1996 Dec; 74(11):1693-8. PubMed ID: 8956779
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of intracytoplasmic nm23-H1 expression in diffuse large B-cell lymphoma.
Niitsu N; Nakamine H; Okamoto M; Akamatsu H; Higashihara M; Honma Y; Okabe-Kado J; Hirano M
Clin Cancer Res; 2004 Apr; 10(7):2482-90. PubMed ID: 15073128
[TBL] [Abstract][Full Text] [Related]
15. Differentiation inhibitory factor Nm23 as a prognostic factor for acute myeloid leukemia.
Okabe-Kado J; Kasukabe T; Honma Y
Leuk Lymphoma; 1998 Dec; 32(1-2):19-28. PubMed ID: 10036998
[TBL] [Abstract][Full Text] [Related]
16. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia.
Yokoyama A; Okabe-Kado J; Sakashita A; Maseki N; Kaneko Y; Hino K; Tomoyasu S; Tsuruoka N; Kasukabe T; Honma Y
Blood; 1996 Nov; 88(9):3555-61. PubMed ID: 8896423
[TBL] [Abstract][Full Text] [Related]
17. Combined analysis of differentiation inhibitory factor nm23-H1 and nm23-H2 as prognostic factors in acute myeloid leukaemia.
Wakimoto N; Yokoyama A; Okabe-Kado J; Nagata N; Motoyoshi K; Honma Y
Br J Cancer; 1998 Jun; 77(12):2298-303. PubMed ID: 9649149
[TBL] [Abstract][Full Text] [Related]
18. The association of nm23-H1 expression with a poor prognosis in patients with peripheral T-cell lymphoma, not otherwise specified.
Niitsu N
J Clin Exp Hematop; 2014; 54(3):171-7. PubMed ID: 25501107
[TBL] [Abstract][Full Text] [Related]
19. A clinicopathological study of nm23-H1 expression in classical Hodgkin's lymphoma.
Niitsu N; Nakamine H; Okamoto M; Tamaru JI; Hirano M
Ann Oncol; 2008 Nov; 19(11):1941-6. PubMed ID: 18647967
[TBL] [Abstract][Full Text] [Related]
20. Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis.
Pavelić K; Kapitanović S; Radosević S; Bura M; Seiwerth S; Pavelić LJ; Unusić J; Spaventi R
J Mol Med (Berl); 2000; 78(2):111-8. PubMed ID: 10794547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]